drugset / Trial / NCT06428630

Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus

NCT06428630

Phase 0 Withdrawn Tufts University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to see the amount of systemic absorption of a standard dose of dexamethasone oral rinse for patients with symptomatic oral lichen planus (OLP) or oral lichenoid reactions (OLR) and healthy subjects (those who do not have OLP or OLR aka the control group).

Timeline

Start
2025-05-01
Primary completion
2026-09-01
Completion
2027-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.5 mg Topical

Indications